나이아젠 바이오사이언스
NAGE · 최근 11건
10
매수
1
매도
+$735K
순매수
거래 내역
Fried Robert N
Chief Executive Officer · 2026. 6. 30.
+$3K
매수
Pamir Ozan
Chief Financial Officer · 2026. 6. 30.
+$12K
매수
Lopez Carlos Luis
SVP, General Counsel · 2026. 6. 30.
+$6K
매수
Ng Wang Yu Gary
Director · 2026. 6. 24.
+$110K
매수
Patrick Kristin
Director · 2026. 6. 24.
+$110K
매수
YU Wing Tak Wendy
Director · 2026. 6. 24.
+$110K
매수
Rubin Steven D
Director · 2026. 6. 24.
+$110K
매수
Jaksch Frank L Jr
Director · 2026. 6. 24.
+$110K
매수
Cohen Ann
Director · 2026. 6. 24.
+$110K
매수
Shahbazi Hamed
Director · 2026. 6. 24.
+$110K
매수
Fried Robert N
Chief Executive Officer · 2026. 4. 24.
−$52K
매도